Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease.
Noori M, Dastyafteh N, Safapoor S, Khalili Ghomi M, Tanideh R, Zomorodian K, Hamedifar H, Dara M, Zare S, Irajie C, Javanshir S, Rastegar H, Panahi N, Larijani B, Mahdavi M, Hajimiri MH, Iraji A. Noori M, et al. Among authors: rastegar h. Int J Biol Macromol. 2023 Dec 31;253(Pt 7):127392. doi: 10.1016/j.ijbiomac.2023.127392. Epub 2023 Oct 11. Int J Biol Macromol. 2023. PMID: 37827412
Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T. Saeedi M, et al. Among authors: rastegar h. Bioorg Chem. 2019 Mar;83:161-169. doi: 10.1016/j.bioorg.2018.10.023. Epub 2018 Oct 11. Bioorg Chem. 2019. PMID: 30366316
Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.
Asgari MS, Mohammadi-Khanaposhtani M, Sharafi Z, Faramarzi MA, Rastegar H, Nasli Esfahani E, Bandarian F, Ranjbar Rashidi P, Rahimi R, Biglar M, Mahdavi M, Larijani B. Asgari MS, et al. Among authors: rastegar h. Mol Divers. 2021 May;25(2):877-888. doi: 10.1007/s11030-020-10072-8. Epub 2020 Mar 18. Mol Divers. 2021. PMID: 32189236
Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.
Pedrood K, Sherafati M, Mohammadi-Khanaposhtani M, Asgari MS, Hosseini S, Rastegar H, Larijani B, Mahdavi M, Taslimi P, Erden Y, Günay S, Gulçin İ. Pedrood K, et al. Among authors: rastegar h. Int J Biol Macromol. 2021 Feb 15;170:1-12. doi: 10.1016/j.ijbiomac.2020.12.121. Epub 2020 Dec 19. Int J Biol Macromol. 2021. PMID: 33352155
Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.
Sherafati M, Mirzazadeh R, Barzegari E, Mohammadi-Khanaposhtani M, Azizian H, Sadegh Asgari M, Hosseini S, Zabihi E, Mojtabavi S, Ali Faramarzi M, Mahdavi M, Larijani B, Rastegar H, Hamedifar H, Hamed Hajimiri M. Sherafati M, et al. Among authors: rastegar h. Bioorg Chem. 2021 Apr;109:104703. doi: 10.1016/j.bioorg.2021.104703. Epub 2021 Feb 8. Bioorg Chem. 2021. PMID: 33609917
New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies.
Mirzazadeh R, Asgari MS, Barzegari E, Pedrood K, Mohammadi-Khanaposhtani M, Sherafati M, Larijani B, Rastegar H, Rahmani H, Mahdavi M, Taslimi P, Üç EM, Gulçin İ. Mirzazadeh R, et al. Among authors: rastegar h. Arch Pharm (Weinheim). 2021 Sep;354(9):e2000471. doi: 10.1002/ardp.202000471. Epub 2021 May 17. Arch Pharm (Weinheim). 2021. PMID: 33999440
149 results